|
BCL7B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.101300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.860900E-03 |
| Normal-vs-Stage2 |
1.602180E-01 |
| Normal-vs-Stage3 |
8.270200E-02 |
| Normal-vs-Stage4 |
3.507800E-01 |
| Stage1-vs-Stage2 |
7.400400E-01 |
| Stage1-vs-Stage3 |
5.471000E-01 |
| Stage1-vs-Stage4 |
2.200200E-01 |
| Stage2-vs-Stage3 |
9.158400E-01 |
| Stage2-vs-Stage4 |
5.328800E-01 |
| Stage3-vs-Stage4 |
5.320200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.056000E-02 |
| Normal-vs-AfricanAmerican |
1.685670E-02 |
| Normal-vs-Asian |
4.154400E-01 |
| Caucasian-vs-AfricanAmerican |
1.231190E-01 |
| Caucasian-vs-Asian |
9.852200E-01 |
| AfricanAmerican-vs-Asian |
5.993800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.240200E-02 |
| Normal-vs-Female |
9.875900E-03 |
| Male-vs-Female |
6.815400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.195800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.072550E-01 |
| Normal-vs-Age(61-80Yrs) |
4.478700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.239900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.104000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.589400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.527390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.292980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.684200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.083800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.368200E-01 |
| Normal-vs-Grade 2 |
3.004000E-02 |
| Normal-vs-Grade 3 |
6.028000E-02 |
| Normal-vs-Grade 4 |
4.300400E-02 |
| Grade 1-vs-Grade 2 |
6.115600E-01 |
| Grade 1-vs-Grade 3 |
5.990600E-01 |
| Grade 1-vs-Grade 4 |
7.169400E-01 |
| Grade 2-vs-Grade 3 |
9.232400E-01 |
| Grade 2-vs-Grade 4 |
4.994000E-01 |
| Grade 3-vs-Grade 4 |
4.700800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.820300E-03 |
| Normal-vs-ccB subtype |
1.573840E-01 |
| ccA subtype-vs-ccB subtype |
1.671380E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.076300E-02 |
| Normal-vs-N1 |
4.462200E-01 |
| N0-vs-N1 |
9.195600E-01 |
|
|
